ArticleOncotarget2014

Melanoma cell therapy: Endothelial progenitor cells as shuttle of the MMP12 uPAR-degrading enzyme.

Anna Laurenzana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.